⚠ Evidence warning: Clinical trials or other evidence do not support the claim that standardized capsules are the practical option for clinical use. This page keeps it as a report of what people, websites or other media say.

Bitter Melon (Momordica charantia)

Bitter melon vine on a trellis with warty green fruits, lobed leaves and yellow flowers
Bitter melon vine with fruit and yellow flowers
Sliced green bitter melon showing pith and seeds beside a ripe orange fruit with red seed arils
Inside the fruit: green flesh, pith and seeds; a ripe fruit shows red arils
Bowl of stir-fried bitter melon crescents with egg and garlic
Bitter melon in an everyday stir-fry
Bitter Melon (Momordica charantia)

Table of Contents

  1. Traditional Use Across Asia and the Caribbean
  2. Active Compounds
  3. Blood Sugar Regulation
  4. Lipid Metabolism and Body Composition
  5. Antimicrobial and Antiviral Activity
  6. Culinary Preparation
  7. Forms and Preparations
  8. Dosage
  9. Cautions and Contraindications
  10. Conditions It Is Used For
  11. Featured Videos

Traditional Use Across Asia and the Caribbean

Bitter melon (also called bitter gourd, karela in Hindi, kŭgua in Chinese) is a tropical vine in the cucumber family whose intensely bitter, warty fruit has been eaten as both food and medicine for centuries. Genetic studies trace the wild plant to Africa, with domestication in Asia, and it became deeply established in Ayurvedic, Traditional Chinese, and Caribbean folk medicine — most consistently as a remedy for high blood sugar and diabetes. — the fuller story is told in the dedicated History & Traditional Use article.

Back to Table of Contents

Active Compounds

Bitter melon contains a complex mix of bioactive constituents:

Back to Table of Contents

Blood Sugar Regulation

Bitter melon's antidiabetic action operates through multiple complementary mechanisms, more diverse than any single pharmaceutical drug:

Clinical trials have produced mixed but generally positive results. A 2024 meta-analysis of eight randomized controlled trials in 423 people with type 2 diabetes (Zhang and colleagues) found modest but statistically significant reductions in fasting glucose and hemoglobin A1c (HbA1c), with hemoglobin A1c falling by about 0.38 percentage points. Effects are smaller than those of berberine or pharmaceutical metformin; bitter melon is also an everyday vegetable.

Back to Table of Contents

Lipid Metabolism and Body Composition

Beyond glucose, bitter melon has been studied for several markers of metabolic health. Animal studies have shown reductions in total cholesterol, low-density lipoprotein (LDL), and triglycerides, along with increases in high-density lipoprotein (HDL). In people the picture is narrower: the 2024 meta-analysis of eight randomized trials in people with type 2 diabetes (Zhang and colleagues) found total cholesterol fell by 0.38 mmol/L but no significant change in triglycerides, HDL or LDL, and a 2023 meta-analysis of nine randomized trials (Laczkó-Zöld and colleagues) found no significant effect on HDL, LDL or total cholesterol. The seed-derived conjugated linolenic acids appear to activate PPAR-alpha and PPAR-gamma receptors, which regulate fatty acid metabolism and adipocyte differentiation.

In overweight and obese individuals with insulin resistance, bitter melon supplementation has been shown to reduce visceral adipose tissue and improve waist-to-hip ratio when combined with caloric restriction, although the magnitude of effect is modest.

Back to Table of Contents

Antimicrobial and Antiviral Activity

Bitter melon has demonstrated activity against a range of bacterial, viral, and parasitic pathogens in laboratory studies. The MAP30 protein isolated from bitter melon seeds has been studied for activity against herpes simplex virus and human immunodeficiency virus (HIV) in cell culture. Traditional use for intestinal parasites, malaria, and dysentery may have a basis in cucurbitacin and momordicin antimicrobial effects.

Clinical evidence in human infectious disease is limited; the antimicrobial findings come from laboratory studies. Integrative practitioners describe it as an adjunct in chronic dysbiosis and as part of broader protocols.

Back to Table of Contents

Culinary Preparation

Bitter melon is most commonly consumed as food in Asia. Traditional preparation reduces but does not eliminate the bitterness:

Doses used for diabetes generally exceed what most people eat as food; the early clinical trials used bitter melon juice, fruit and dried powder (Basch and colleagues, 2003). Supplementation with standardized capsules is the practical option for clinical use.

Back to Table of Contents

Forms and Preparations

Back to Table of Contents

Dosage

Amounts commonly described for bitter melon:

Back to Table of Contents

Cautions and Contraindications

Back to Table of Contents

Key Research Papers

  1. Khanna P, Jain SC, Panagariya A, Dixit VP. Hypoglycemic activity of polypeptide-p from a plant source. Journal of Natural Products. 1981;44(6):648–655. — PubMed PMID: 7334382
  2. Raman A, Lau C. Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine. 1996;2(4):349–362. — PubMed PMID: 23194773
  3. Zhang X, Zhao Y, Song Y, Miao M. Effects of Momordica charantia L. supplementation on glycemic control and lipid profile in type 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials. Heliyon. 2024;10(10):e31126. — PubMed PMID: 38784554
  4. Laczkó-Zöld E, Csupor-Löffler B, Kolcsár EB, et al. The metabolic effect of Momordica charantia cannot be determined based on the available clinical evidence: a systematic review and meta-analysis of randomized clinical trials. Frontiers in Nutrition. 2023;10:1200801. — PubMed PMID: 38274207
  5. Basch E, Gabardi S, Ulbricht C. Bitter melon (Momordica charantia): a review of efficacy and safety. American Journal of Health-System Pharmacy. 2003;60(4):356–359. — PubMed PMID: 12625217

PubMed Topic Searches

The following PubMed search links provide curated entry points into the published clinical and mechanistic literature on Bitter Melon (Momordica charantia). Each link opens directly in PubMed at the National Library of Medicine.

  1. Bitter melon for type 2 diabetes glycemic control — PubMed: Momordica charantia diabetes
  2. Bitter melon and insulin resistance — PubMed: Momordica insulin resistance
  3. Bitter melon active compounds: charantin, vicine, polypeptide-p — PubMed: Momordica charantin polypeptide-p
  4. Bitter melon and cholesterol / triglycerides — PubMed: Momordica lipid cholesterol
  5. Bitter melon antiviral activity — PubMed: Momordica antiviral
  6. Bitter melon and cancer cell apoptosis — PubMed: Momordica charantia cancer apoptosis
  7. Safety and adverse effects of bitter melon — PubMed: Momordica safety

External Authoritative Resources

  1. NCCIH — Herbs at a Glance
  2. MedlinePlus — Herbs and Supplements
  3. PubMed — All research on Momordica charantia

Back to Table of Contents


Conditions Bitter Melon Is Used For

Each condition below links to its page. The coloured half of every capsule shows how much human evidence supports this herb for that specific use — traditional use is history, not proof, and is marked as such.

Human trial evidenceSmall or mixed trialsTraditional use onlyDocumented harm or negative evidence

Connections

Back to Table of Contents

Bitter Melon — scientific infographic poster